Vanda Pharmaceuticals Future Growth

How is Vanda Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

3/6

Future Growth Score 3/6

42.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:VNDA - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	286	41	N/A	N/A	1
12/31/2024	277	35	N/A	N/A	1
12/31/2023	266	28	N/A	N/A	1
9/30/2022	258	6	49	49	N/A
6/30/2022	263	11	45	46	N/A
3/31/2022	266	18	59	59	N/A
12/31/2021	269	33	64	64	N/A
9/30/2021	268	34	56	57	N/A
6/30/2021	259	32	55	57	N/A
3/31/2021	253	32	60	62	N/A
12/31/2020	248	23	50	52	N/A
9/30/2020	241	19	41	42	N/A
6/30/2020	241	114	38	39	N/A
3/31/2020	237	117	34	35	N/A
12/31/2019	227	116	45	46	N/A
9/30/2019	219	122	50	51	N/A
6/30/2019	209	28	53	54	N/A
3/31/2019	197	22	12	38	N/A
12/31/2018	193	25	5	30	N/A
9/30/2018	184	13	-7	18	N/A
6/30/2018	177	1	-14	12	N/A
3/31/2018	171	-5	4	5	N/A
12/31/2017	165	-16	-4	-2	N/A
9/30/2017	159	-14	-9	-7	N/A
6/30/2017	156	-10	-10	-8	N/A
3/31/2017	150	-13	-10	-9	N/A
12/31/2016	146	-18	-10	-8	N/A
9/30/2016	140	-32	-9	-7	N/A
6/30/2016	129	-41	N/A	-13	N/A
3/31/2016	121	-42	N/A	2	N/A

Earnings vs Savings Rate: VNDA's forecast earnings growth (42.5% per year) is above the savings rate (2.1%).

Earnings vs Market: VNDA's earnings (42.5% per year) are forecast to grow faster than the US market (14.2% per year).

High Growth Earnings: VNDA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: VNDA's revenue (2.6% per year) is forecast to grow slower than the US market (7.2% per year).

High Growth Revenue: VNDA's revenue (2.6% per year) is forecast to grow slower than 20% per year.

Future ROE: Insufficient data to determine if VNDA's Return on Equity is forecast to be high in 3 years time